Related Experiment Videos

Prothrombin time in first week of life with special reference to vitamin K administration

G P Mathur1, S Mathur, R Goenka

  • 1Department of Pediatrics, GSVM Medical College, Kanpur.

Indian Pediatrics
|July 1, 1990
PubMed

Insights

Vitamin K supplementation is crucial for newborns experiencing birth hypoxia or prematurity, as it significantly improves prothrombin time. Healthy, full-term infants do not require this intervention.

Area of Science:

  • Neonatal Medicine
  • Pediatric Hematology

Background:

  • Prothrombin time (PT) is a critical measure of blood coagulation.
  • Neonatal hemostasis differs from adults, with lower levels of vitamin K-dependent clotting factors.
  • Prematurity and birth complications like hypoxia can exacerbate coagulation disturbances in newborns.

Purpose of the Study:

  • To assess prothrombin time in a cohort of neonates.
  • To determine the impact of prematurity and birth hypoxia on prothrombin time.
  • To evaluate the efficacy of Vitamin K administration in correcting altered prothrombin times.

Main Methods:

  • Prothrombin time was measured in 100 neonates (80 full-term, 20 preterm).
  • Subgroups included healthy and sick full-term infants.
  • Vitamin K was administered to anoxic neonates, and prothrombin time was re-evaluated.

Main Results:

  • Prothrombin time was significantly altered in neonates with birth hypoxia and prematurity (p < 0.001).
  • Vitamin K administration led to significant improvement in prothrombin time within 48-72 hours in anoxic neonates (p < 0.001).
  • Bleeding complications occurred in four newborns, primarily in preterm infants who did not receive Vitamin K.

Conclusions:

  • Vitamin K is recommended for all preterm infants and those experiencing difficult deliveries.
  • Routine Vitamin K administration is not necessary for healthy, full-term newborns.
  • Prompt Vitamin K supplementation can prevent bleeding complications in at-risk neonates.

Related Concept Videos